| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | L Lo Muzio | |
| G Campisi | |||
| O Di Fede | |||
| F Giancola | |||
| L Lo Russo | |||
| P2860 | cites work | Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases | Q38105361 |
| Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer | Q43111250 | ||
| Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone | Q46124362 | ||
| P433 | issue | Suppl 2 | |
| P304 | page(s) | 20-21 | |
| P577 | publication date | 2013-10-24 | |
| P1433 | published in | Annali di stomatologia | Q26842375 |
| P1476 | title | Osteonecrosis of the jaw related to everolimus and bisphosphonate: a unique case report? | |
| P478 | volume | 4 |
| Q40064245 | A Case of Pentastomiasis at the Left Maxilla Bone in a Patient with Thyroid Cancer. |
| Q28072449 | Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches |
| Q37701817 | Osteonecrosis of the jaw associated with everolimus: A case report |
| Q37525339 | Osteonecrosis of the jaw associated with ziv-aflibercept |
| Q64101769 | Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology |
| Q92272586 | Review and update on drugs related to the development of osteonecrosis of the jaw |
| Q36292333 | The Prevention of Medication-related Osteonecrosis of the Jaw. |
Search more.